Terms: = Uterine cancer AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814
33 results:
1. Cervical cancer prevention: Feasibility of self-sampling and HPV testing in rural and urban areas of Bolivia: An observational study.
Carozzi FM; Royder Yanez R; Paganini I; Sani C; Cannistrà S; Matucci M; von Borries S; Traina S
PLoS One; 2024; 19(3):e0292605. PubMed ID: 38451956
[TBL] [Abstract] [Full Text] [Related]
2. Temporal trends in incidence and mortality of cervical cancer in China from 1990 to 2019 and predictions for 2034.
Li S; Huang M; Zhu Y; Zeng H; Zhang F
Eur J Cancer Prev; 2024 May; 33(3):252-261. PubMed ID: 37997908
[TBL] [Abstract] [Full Text] [Related]
3. Differences in breast and cervical cancer screening between West and East Germany: a secondary analysis of a german nationwide health survey.
Großmann LM; Napierala H; Herrmann WJ
BMC Public Health; 2023 Oct; 23(1):1931. PubMed ID: 37798695
[TBL] [Abstract] [Full Text] [Related]
4. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017.
Park M; Lim J; Lee JA; Park HJ; Park BK; Lim MC; Park SY; Won YJ
Gynecol Oncol; 2021 Oct; 163(1):79-84. PubMed ID: 34392955
[TBL] [Abstract] [Full Text] [Related]
5. Biopsychosocial risk factors and knowledge of cervical cancer among young women: A case study from Kenya to inform HPV prevention in Sub-Saharan Africa.
Ngune I; Kalembo F; Loessl B; Kivuti-Bitok LW
PLoS One; 2020; 15(8):e0237745. PubMed ID: 32817627
[TBL] [Abstract] [Full Text] [Related]
6. Expression of immune cell markers and tumor markers in patients with cervical cancer.
Zhang L; Zhang H; Huang Y; Xi X; Sun Y
Int J Gynecol Cancer; 2020 Jul; 30(7):969-974. PubMed ID: 32518078
[TBL] [Abstract] [Full Text] [Related]
7. Invasive cervical cancer after treatment of CIN.
Herbert A; Culora G; McLean E; Kubba AA;
J Am Soc Cytopathol; 2019; 8(6):324-332. PubMed ID: 31523013
[TBL] [Abstract] [Full Text] [Related]
8. Future projection of cancer patients with cardiovascular disease in Japan by the year 2039: a pilot study.
Okura Y; Takayama T; Ozaki K; Tanaka H; Kikuchi A; Saito T; Tanigawa T; Takii Y; Seki H; Takenouchi T; Chou T; Sato N; Tanabe N; Minamino T
Int J Clin Oncol; 2019 Aug; 24(8):983-994. PubMed ID: 30903421
[TBL] [Abstract] [Full Text] [Related]
9. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
[TBL] [Abstract] [Full Text] [Related]
10. Higher prevalence of human papillomavirus infection in adolescent and young adult girls belonging to different Indian tribes with varied socio-sexual lifestyle.
Sharma K; Kathait A; Jain A; Kujur K; Raghuwanshi S; Bharti AC; Saklani AC; Das BC
PLoS One; 2015; 10(5):e0125693. PubMed ID: 25954813
[TBL] [Abstract] [Full Text] [Related]
11. Black and white women in Maryland receive different treatment for cervical cancer.
Fleming S; Schluterman NH; Tracy JK; Temkin SM
PLoS One; 2014; 9(8):e104344. PubMed ID: 25121587
[TBL] [Abstract] [Full Text] [Related]
12. Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009.
Rositch AF; Nowak RG; Gravitt PE
Cancer; 2014 Jul; 120(13):2032-8. PubMed ID: 24821088
[TBL] [Abstract] [Full Text] [Related]
13. Cervical cancer screening in the US-Mexico border region: a binational analysis.
Herrera DG; Schiefelbein EL; Smith R; Rojas R; Mirchandani GG; McDonald JA
Matern Child Health J; 2012 Dec; 16 Suppl 2(0 2):298-306. PubMed ID: 22965734
[TBL] [Abstract] [Full Text] [Related]
14. Geographical distribution and demographic characteristics of gestational trophoblastic disease.
Soares PD; Maestá I; Costa OL; Charry RC; Dias A; Rudge MV
J Reprod Med; 2010; 55(7-8):305-10. PubMed ID: 20795343
[TBL] [Abstract] [Full Text] [Related]
15. Cervical cancer: cytological cervical screening in Iceland and implications of HPV vaccines.
Sigurdsson K
Cytopathology; 2010 Aug; 21(4):213-22. PubMed ID: 20646020
[TBL] [Abstract] [Full Text] [Related]
16. Results of a cervical cancer screening programme from an area of Barcelona (Spain) with a large immigrant population.
Casamitjana M; Sala M; Ochoa D; Fusté P; Castells X; Alameda F;
Eur J Public Health; 2009 Oct; 19(5):499-503. PubMed ID: 19435798
[TBL] [Abstract] [Full Text] [Related]
17. Correlation between NDRG1 and PTEN expression in endometrial carcinoma.
Chen J; Li S; Yang Z; Lu G; Hu H
Cancer Sci; 2008 Apr; 99(4):706-10. PubMed ID: 18377423
[TBL] [Abstract] [Full Text] [Related]
18. Cervical screening: why young women should be encouraged to be screened.
Herbert A; Holdsworth G; Kubba AA
J Fam Plann Reprod Health Care; 2008 Jan; 34(1):21-5. PubMed ID: 18201402
[TBL] [Abstract] [Full Text] [Related]
19. Longitudinal trends in cervical cytological lesions and the effect of risk factors. A 30-year overview.
Sigurdsson K; Sigvaldason H
Acta Obstet Gynecol Scand; 2006; 85(3):350-8. PubMed ID: 16553185
[TBL] [Abstract] [Full Text] [Related]
20. [Analysis of epidemiologic risk factors for endometrial cancer].
Bratos K; Roszak A; Cikowska-Woźniak E; Niecewicz P
Ginekol Pol; 2002 Nov; 73(11):945-50. PubMed ID: 12722379
[TBL] [Abstract] [Full Text] [Related]
[Next]
